Parallel Advisors’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-350
| Closed | – | – | 3672 |
|
|
2024
Q3 | $0 | Hold |
350
| – | – | ﹤0.01% | 3536 |
|
|
2024
Q2 | $0 | Hold |
350
| – | – | ﹤0.01% | 3483 |
|
|
2024
Q1 | $13 | Hold |
350
| – | – | ﹤0.01% | 3271 |
|
|
2023
Q4 | $19 | Hold |
350
| – | – | ﹤0.01% | 3282 |
|
|
2023
Q3 | $31 | Hold |
350
| – | – | ﹤0.01% | 3314 |
|
|
2023
Q2 | $32 | Hold |
350
| – | – | ﹤0.01% | 3324 |
|
|
2023
Q1 | $91 | Hold |
350
| – | – | ﹤0.01% | 3340 |
|
|
2022
Q4 | $74 | Hold |
350
| – | – | ﹤0.01% | 3282 |
|
|
2022
Q3 | $0 | Hold |
350
| – | – | ﹤0.01% | 3699 |
|
|
2022
Q2 | $0 | Hold |
350
| – | – | ﹤0.01% | 3566 |
|
|
2022
Q1 | $0 | Hold |
350
| – | – | ﹤0.01% | 3467 |
|
|
2021
Q4 | $0 | Hold |
350
| – | – | ﹤0.01% | 3479 |
|
|
2021
Q3 | $1K | Hold |
350
| – | – | ﹤0.01% | 3033 |
|
|
2021
Q2 | $1K | Hold |
350
| – | – | ﹤0.01% | 2904 |
|
|
2021
Q1 | $1K | Hold |
350
| – | – | ﹤0.01% | 2761 |
|
|
2020
Q4 | $1K | Hold |
350
| – | – | ﹤0.01% | 2544 |
|
|
2020
Q3 | $1K | Hold |
350
| – | – | ﹤0.01% | 2537 |
|
|
2020
Q2 | $1K | Hold |
350
| – | – | ﹤0.01% | 2415 |
|
|
2020
Q1 | $0 | Buy |
+350
| New | +$386 | ﹤0.01% | 2808 |
|